347 results about "Poloxamer" patented technology

The invention provides a formula of a temperature-sensitive recombinant human epidermal growth factor hydrogel composition, temperature-sensitive gel takes poloxamer as a drug carrier, and a terminal sterilization mode is filtration sterilization. The temperature-sensitive recombinant human epidermal growth factor hydrogel composition provided by the invention has unique advantages in the aspects of degerming process, temperature sensitivity, stability and practical applicability.

The invention relates to the technical field of western-style clothes processing, in particular to an anti-wrinkle western-style clothes fabric and a processing technology thereof.The anti-wrinkle western-style clothes fabric is prepared by finishing base cloth through finishing liquid, the base cloth is wool blended fabric, and the wool blended fabric comprises wool, polyester fibers, lyocell fibers, spandex and conductive fibers; the finishing liquid is prepared from the following raw materials in parts by weight: 1 to 4 parts of polyoxyethylene sorbitan monooleate, 0.1 to 1 part of cocamidopropyl betaine, 2 to 6 parts of a fiber protecting agent, 80 to 120 parts of carboxyl-terminated hyperbranched polyester, 40 to 60 parts of butanetetracarboxylic acid, 30 to 50 parts of poloxamer, 0.1 to 2 parts of a silane coupling agent, 2 to 4 parts of an aziridine cross-linking agent and 900 to 1100 parts of water; the fabric has the advantage that the crease resistance of the business suit fabric is improved.

The invention discloses periodontitis targeted sustained-release gel based on epithelial training immunization and a preparation method thereof, and relates to the technical field of biological medicine, and the preparation method comprises the following steps: modifying poloxamer, and dissolving the modified poloxamer in anhydrous acetonitrile; the preparation method comprises the following steps: dissolving RGD peptide in a PBS (Phosphate Buffer Solution), adding N-hydroxysuccinimide and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, and activating to obtain an activated RGD peptide solution; adding the activated RGD peptide solution into the modified poloxamer solution, and reacting at room temperature to obtain RGD peptide modified poloxamer; the RGD peptide modified poloxamer solution is mixed with a beta-glucan solution and a TLR2 agonist solution, and the periodontitis targeted slow-release gel is obtained. The gel provided by the invention specifically targets gingival epithelial cells, reduces inflammatory response and promotes periodontal tissue regeneration, has good biocompatibility and slow release performance, and can effectively control periodontitis and prevent relapse.

The invention belongs to the technical field of coal washing flotation reagents, and discloses a synthesis process of an environment-friendly coal washing flotation reagent foaming agent, and the synthesis process comprises the following steps: composite reaction; water phase fusion; according to the method, biodegradable alcohols such as pentanol and sec-octanol are adopted as main raw materials, and poloxamer and glycerol are matched, so that the problem of toxic residue of a traditional hydrocarbon foaming agent is avoided. In the synthesis process, low-boiling-point impurities are removed through molecular sieve filtration and a rotary evaporator, it is ensured that the purity of the raw materials is larger than or equal to 99.5%, the proportion of the final product deionized water reaches 40-50%, the use amount of an organic solvent is greatly reduced, nanoscale wrapping of alcohol molecules by an emulsifier OP-10 is achieved through a gradient water adding method and an ultrasonic-assisted emulsification technology, and the content of the alcohol molecules is reduced. And a microemulsion structure with high interfacial film strength is formed. After lauryl sodium sulfate is added as an auxiliary emulsifier, the strength of an oil-water interfacial film is improved by 30% or above, and the half-life period of foam is prolonged to 1.8 times of that of a traditional process.

The present invention relates to a hydrogel-based drug delivery system that can efficiently deliver the required amount of a drug to a desired location for a longer period of time. The hydrogel-based drug delivery system includes: an amphipathic block copolymer including a mixture of a first poloxamer and a second poloxamer that have different molecular weights; and a protein extract (containing elastin and collagen. A drug delivery composition for promoting tissue regeneration, according to the present invention, is mixed with a drug and introduced into the body, thus increasing the excretion time of the drug in the body, has phase transition properties of a liquid (sol) state at room temperature while being gelled at body temperature, thus being convenient to inject as an injectable agent, can be applied to various body parts.

The invention relates to the technical field of medical biopolymer materials, in particular to a two-component gynecological gel spray and a using method thereof.The two-component gynecological gel spray comprises a first component and a second component, and the first component at least comprises formylated multi-arm polyethylene glycol, formylated poloxamer and a solvent; the second component at least comprises a multi-amino polymer solution, the bi-component solution forms a film in the vagina and is cured in situ, and the vaginal gel has the characteristics of strong adhesion and strong corrosion resistance, can act on the vagina for a long time to realize long-acting treatment, and is more convenient to use and better in effect.

The invention relates to a pharmaceutical composition, which is prepared from adapalene, benzoyl peroxide, a traditional Chinese medicine extract, an acrylamide and acryloyl dimethyl sodium taurate copolymer, a mixture of isohexadecane and polysorbate 80, docusate sodium, EDTA (Ethylene Diamine Tetraacetic Acid) disodium, glycerol, poloxamer 124, propylene glycol and water, the traditional Chinese medicine extract comprises moutan bark, salvia miltiorrhiza, radix rehmanniae recen, radix sophorae flavescentis, coptis chinensis, rheum officinale, scutellaria baicalensis, menthol and borneol. According to the pharmaceutical composition disclosed by the invention, the synergistic antibacterial and anti-keratosis curative effects of adapalene and benzoyl peroxide can be maintained, and meanwhile, the occurrence rate of local skin dryness, erythema, desquamation, burning heat sensation and contact dermatitis can be remarkably reduced.

The application discloses a kind of by polydopamine mesoporous nanoparticles crosslinked sulfhydrylated hyaluronic acid hydrogel and its preparation method and application, with dopamine and 4-formylphenylboronic acid as monomer, with trimethylbenzene as and poloxamer as template agent, in weak alkaline (pH=8.4), oxygen exists in the environment, by the oxidation self-polymerization reaction between monomer Preparation of polydopamine nanoparticles with mesoporous structure.Then the water dispersion of polydopamine nanoparticles is mixed with sulfhydrylated hyaluronic acid solution according to certain proportion, and the hydrogel dressing with injectable property is prepared.The hydrogel is expected to be used as skin wound dressing for the treatment of diabetic wounds.

The invention discloses a blue copper peptide composition for repairing scars and a preparation method of the blue copper peptide composition, and belongs to the technical field of preparation of biological medicine preparations. The composition is prepared from freeze-dried powder of copper blue peptide, polyquaternium-73, asiaticoside, nicotinamide, polydimethylsiloxane, betaine-propylene glycol ionic liquid and a gel matrix. According to the invention, the blue copper peptide is coated in a permeation enhancing system constructed by the betaine-propylene glycol ionic liquid and the HEPES, so that the enzymolysis loss of the blue copper peptide is reduced, and the biological activity of the blue copper peptide is maintained; a temperature-sensitive gel matrix is constructed by carboxyl esterified modified sodium alginate and poloxamer, the carboxyl esterified modified sodium alginate is prepared by grafting n-butyl alcohol to a hydrophilic main chain of sodium alginate through a Fischer esterification method, the gel matrix is in a liquid state at normal temperature, after the gel matrix is smeared on a scar part, the gel matrix is converted into semi-solid gel under the influence of body temperature, and slow and continuous release of blue copper peptide can be achieved. The traditional Chinese medicine composition has the effect of repairing scars and is suitable for chronic scars needing long-term nursing.

Disclosed is a composition for treating a joint disease or a connective tissue disease, a composition for cartilage regeneration, or a composition for treating an inflammatory disease, each of the compositions containing dextran, poloxamer or a mixture thereof. The composition stays in the joint or connective tissue for a long time due to the shock-absorbing effect, coating effect or anti-inflammation effect, relieves the shock, covers a damaged portion in a specific manner thereto, or reduces inflammation of an adhered portion. Thus, the composition may be useful for the treatment of the joint disease, the connective tissue disease, or for the cartilage regeneration.

Improved compositions and processes for preparing mRNA-loaded lipid nanoparticles (mRNA-LNPs) are provided.SOLUTION: (i) mixing a mRNA solution with a lipid solution in the presence of 0.05% to less than 3% of a poloxamer prior to removal, wherein the lipid solution comprises one or more cationic lipids, one or more non-cationic lipids, and less than 0.5% of one or more PEG-modified lipids or PEG, and (ii) removing the poloxamer, wherein upon removal less than 0.05% of the poloxamer remains.SELECTED DRAWING: Figure 2

The application discloses a live vaccine heat-resistant protective agent and a preparation method and application thereof, which is composed of the following components in mass volume percentage: 3-5% of glucose, 1-3% of thiourea, 5-8% of lactose, 0.5-1% of ascorbic acid, 1-3% of glycine, 0.5-1% of poloxamer 188, 1-2% of povidone K30, 3-6% of tert-butyl alcohol, and the balance is water for injection. The application has simple components, easily available raw materials and simple preparation method, can effectively reduce the loss of virus antigens in the freeze-drying process when the live vaccine for small ruminant pestivirus is prepared, and can ensure the immunization efficacy and long-term stable storage of the live vaccine for small ruminant pestivirus.

This application belongs to the field of biomedicine, specifically relating to a method for preparing an antitumor composition for pets, aiming to solve the technical problems of low bioavailability, poor stability, and poor drug administration compliance of poorly soluble active ingredients in antitumor drugs for pets. The method includes: a raw material pretreatment step, in which curcumin, resveratrol, quercetin, green tea polyphenols, and astragalus polysaccharides are pulverized and sieved separately; an organic phase preparation step, in which egg yolk lecithin and solid lipids are dissolved in an ethanol-acetone mixed solvent, and curcumin and resveratrol are added and dissolved by stirring in a water bath; an aqueous phase preparation step, in which poloxamer F68 is dissolved in purified water and dissolved in a water bath; a high-pressure homogenization step, in which a nanoemulsion containing a solid lipid core is prepared; a moderately polar component encapsulation step, in which quercetin and green tea polyphenols are ultrasonically dispersed and then added dropwise to the nanoemulsion; a freeze-drying step, in which a nano-lyophilized powder is obtained; and an outer hydrophilic component coating step, in which astragalus polysaccharides are sprayed or adsorbed onto the surface of the freeze-dried powder. The composition obtained by this method is a core-shell multilayer nanoparticle with a core consisting of curcumin and resveratrol encapsulated by solid lipids, a middle shell adsorbing quercetin and green tea polyphenols, and an outer shell coated with astragalus polysaccharides. This application utilizes the above-mentioned layered encapsulation technology to achieve stable co-encapsulation of multiple antitumor active ingredients, improve the bioavailability of poorly soluble components, optimize drug stability, and enhance antitumor effects through multi-target synergistic effects. Simultaneously, it endows the composition with immunomodulatory functions and sustained-release properties. The composition can be formulated into a nano-lyophilized powder form, making it easy to add to pet food or formulate into a paste for administration, improving pet drug compliance. Figure 2 is a schematic diagram of the three-layer core-shell nanoparticle structure of the composition of this invention.

The invention discloses a preparation method of an intestinal canal filling temperature-sensitive gel injection for gastrointestinal anastomosis guided by an ultrasonic endoscope, and belongs to the technical field of regenerative medicine. According to the specific method, poloxamer, chitosan, polycarbophil, polyvinylpyrrolidone, iohexol and methylene blue are utilized to construct the novel intestinal canal filling temperature-sensitive gel injection. The injection can be injected into the anastomotic intestinal segment of the small intestine by using a conventional nasobiliary drainage tube which is clinically used at present, and the injection becomes viscous immediately under the action of the pH value of the small intestine after injection, so that the injection is inhibited from spreading all around. Meanwhile, the injection is quickly converted into high-strength hydrogel under the action of body temperature, and the hydrogel is adhered to small intestine mucosa to inhibit gel sliding. Therefore, the injection can form a section of gel on a target small intestine section, local immobilization filling and supporting of the target small intestine section are achieved, development can be achieved, the operation difficulty of intestinal tube puncture and stent placement in gastrointestinal anastomosis guided by an ultrasonic endoscope can be greatly reduced, the operation efficiency and the success rate are improved, and the operation cost is reduced. The dosage is less than that of normal saline which is conventionally used clinically, and the effect is better. Moreover, the gel temperature can be reduced by injecting low-temperature normal saline after the operation, so that the gel is thoroughly dissolved into a solution and discharged out of the body, and the phenomenon that the gel remains in the intestinal canal after the operation to cause obstruction is avoided. Therefore, the novel intestinal canal filling temperature-sensitive gel injection has very important clinical practical application value for gastrointestinal anastomosis guided by an ultrasonic endoscope.

The invention discloses an alfacalcidol emulsion and a preparation method thereof, the pH value of the alfacalcidol emulsion is 6.5-8.0, and each 1000 ml of the alfacalcidol emulsion comprises 1-30 g of alfacalcidol, 100-300 g of oil for injection, 6-20 g of a phospholipid emulsifier, 0-20 g of poloxamer 188, 20-30 g of an osmotic pressure regulator and a proper amount of water. The preparation method of the drug-loaded fat emulsion injection comprises the following steps: preparing an oil phase; preparing a water phase; preparing a primary emulsion; performing high-pressure homogenization; adjusting the pH value; and sterilizing and storing. The alfacalcidol serves as an oil-soluble substance, can be dissolved in small oil drops (emulsion particles) of the emulsion or on an interfacial film, and can keep stable physicochemical properties and enhance the slow release performance in the storage process under certain conditions, so that the drug effect time is prolonged.

The invention belongs to the technical field of biological medicine, and discloses an injectable hydrogel combined reagent, self-curing conductive hydrogel and application thereof. The injectable hydrogel combined reagent provided by the invention comprises a solution A and a solution B, the solution A is a first precursor solution formed by dissolving modified poloxamer PFUDAm and ammonium persulfate in deionized water; the solution B is a second precursor solution formed by dissolving N-isopropylacrylamide NIPAM, ferrous gluconate and PEDOT: PSS in deionized water, after the injectable hydrogel combined reagent is mixed in a duplex injection mode, PFUDAm, poly (N-isopropylacrylamide) and PEDOT: PSS are subjected to an oxidation-reduction reaction of ammonium sulfate and ferrous gluconate to initiate polymerization, and the self-curing conductive hydrogel is constructed. The self-curing conductive hydrogel has controllable curing time, and the self-curing conductive hydrogel has excellent swelling resistance, conductivity and good elasticity and toughness, and is expected to be combined with a cardiac pacemaker to be applied to treatment of arrhythmia.

An object of the present invention is to provide a cell culture method and a production method for a product, in which an occurrence of aggregates in foam is suppressed.According to the present invention, there is provided a cell culture method of culturing cells at a cell density of 30×106 cells / mL or more and 400×106 cells / mL or less in a culture solution, the method including: step A of adjusting a poloxamer concentration in a foam liquid constituting foam to be 6 times or less a poloxamer concentration in the culture solution; or step B of adjusting a viscosity of the foam liquid constituting the foam to be 1.5 mPa·s or less under conditions of 35° C. or higher and 38° C. or lower.

The invention discloses a supramolecular hydrogel composition as well as a preparation method and application thereof, and belongs to the technical field of beauty treatment. The supramolecular hydrogel composition provided by the invention is prepared from the following raw materials in percentage by mass: the balance of water; 2 to 30 percent of poloxamer; 1-35% of an active substance; 0.5%-20% of a cross-linking agent; and 1-20% of polyol. The supramolecular hydrogel composition provided by the invention can significantly reduce the irritation to the skin on the basis of effectively improving the content of active substances and the bioavailability of the active substances in the supramolecular hydrogel composition. The invention also provides a preparation method and application of the supramolecular hydrogel composition.

This application provides a premix, kit, and application of a premix for preparing an embolic agent. The premix uses a poloxamer to sodium alginate mass ratio of 9:1 to 20:1, which enables the formation of an injectable solution while maintaining good gel properties, and offers ease of preparation and use.

The invention discloses a manganese urate material, a gel preparation and application thereof, and relates to the technical field of gel preparations. The manganese urate material provided by the invention can enhance anti-tumor immune response, and has good application prospects of adjuvants, vaccines and medicines. Besides, the invention also provides a gel preparation, the preparation is a multifunctional temperature-sensitive hydrogel preparation taking poloxamer as a matrix, and the preparation is combined with artesunate, adriamycin, uric acid and manganese to realize efficient treatment of various tumors such as breast cancer and inhibit postoperative recurrence of the tumors.

This invention provides an injectable cefminox sodium preparation and its preparation method, belonging to the field of pharmaceutical preparation technology. The preparation, by weight, comprises: 1 part of refined cefminox sodium, 0.5 parts of sodium lactate Ringer's solution, 0.2 parts of vitamin B12 injection, 0.1-0.3 parts of a modified composite antioxidant, and 3 parts of physiological saline. The preparation method of the modified composite antioxidant is as follows: S1, add 1 part by weight of poloxamer to 20 parts by weight of distilled water and stir for 6-8 minutes to obtain a solution; S2, after passing 1 part by weight of natural vitamin C through a 100-mesh sieve, mix it into the solution obtained in S1, and sonicate for 10-15 minutes to obtain a vitamin C solution; S3, mix 0.5 parts by weight of vitamin D into the vitamin C solution obtained in S2, and sonicate for 15-20 minutes to obtain the modified composite antioxidant. The formulation of this invention exhibits excellent stability and stable content of cefminox sodium when exposed to environments of 35℃±2℃, 65%±5%RH and natural light, ensuring the safety and reliability of medication.

The present application relates to the technical field of enzyme engineering, and in particular to a kind of complex enzyme microcapsule preparation and its preparation method and application.The above-mentioned complex enzyme microcapsule preparation for ruminant feed, raw materials include by weight ratio: complex enzyme 1-2 parts, complex starch carrier 6-20 parts, poloxamer 188 0.1-1 part, sodium alginate 1-2 parts, plant-derived ingredients 1-2 parts, complex trace elements 0.1-0.3 parts, 0.1-0.2 mol / L calcium chloride solution 100-200 parts;The raw materials of complex starch carrier include by weight ratio: starch 5-15 parts, gelatin 1-5 parts, amylase 0.01-0.1 parts, zinc sulfate heptahydrate 0.01-0.1 parts.The present application has high thermal stability and anti-interference ability, remains stable in rumen environment, can effectively improve the activity of true stomach enzyme, improve feed digestibility, and improve the production performance of ruminant.

The present invention relates to a composition that is used to primarily disrupt and remove biofilm from surfaces. This is achieved using a composition comprising a bacteriophage capable of lysing bacteria selected from one or more of Pseudomonas aeruginosa, Acinetobacter baumanii, Staphylococcus aureus, and E.coli; and a Bacillus bacterial spore in the presence of a specific surfactant of the poloxamer type.

The invention discloses a method for determining the content of poloxamer 124 in the technical field of medical analysis. Liquid chromatography is adopted for detection, and a gel chromatographic column filled with porous silicon dioxide is selected as a chromatographic column; a mobile phase is a trifluoroacetic acid-acetonitrile-water solution; the weight ratio of the mobile phase trifluoroacetic acid to acetonitrile to water is 0.1: (18-22): (78-82); the column temperature is 25-45 DEG C; the temperature of a detector is 60-80 DEG C; the flow velocity of the mobile phase is 0.6-1.0 ml / min; the sample size is 5-20 [mu] l, automatically injecting the sample according to the chromatographic conditions, recording the peak area, and calculating the content according to an area normalization method. The method is high in response value, simple in detection operation and high in product content accuracy, specificity, repeatability, sampling precision, linearity and range all meet the requirements, and the quantitative determination problem of poloxamer 124 is solved.

The invention relates to the technical field of medical materials, and particularly discloses a heparinized polycaprolactone coating as well as a preparation method and application thereof. The preparation method of the heparinized polycaprolactone coating comprises the following steps: adding poloxamer 188 into an MES buffer solution, adding heparin, uniformly stirring, then adding EDC and NHS, and stirring for 40-120 minutes to prepare an activated heparin solution; and dropwise adding the polycaprolactone solution into the activated heparin solution, reacting at room temperature for 90-180 minutes, then dissolving the conjugate into chloroform through rotary evaporation, washing with water, drying with anhydrous MgSO4, precipitating with methanol, filtering the precipitate, and drying in vacuum at 30-40 DEG C to obtain the polycaprolactone heparin. According to the prepared heparinized polycaprolactone coating, local release of heparin is remarkably reduced, and the continuous anticoagulation effect is achieved; and the anticoagulant activity of heparin is reserved, and the coating with good stability is obtained.

The invention discloses an adapalene gel preparation method, which comprises: 1) preparing a carbomer phase: mixing a first solution and a second solution to obtain a mixed solution, and adding carbomer into the mixed solution, the first solution being obtained by mixing edetate disodium and water, the second solution being obtained by mixing edetate disodium and water, and the first solution being obtained by mixing edetate disodium and water; the second solution is obtained by mixing phenoxyethanol, methylparaben and propylene glycol; 2) preparation of adapalene phase: adding water into poloxamer to obtain a solution, and then adding adapalene into the solution; and 3) total mixing: mixing the adapalene phase and the carbomer phase while stirring to obtain a gel precursor, and then degassing, filling and sealing the gel precursor.

A device for delivering one or more bioactive agents is disclosed. The device comprises: a first layer comprising a first biodegradable polymer, the first layer having a first side and a second side, with a plurality of reservoirs containing one or more bioactive agents present on the first side; a second layer comprising a second biodegradable polymer adjacent to the first side of the first layer; and a third layer comprising a third biodegradable polymer, the third layer sealing the first and second layers and including an exposed second layer where at least one surface of the device is not covered by the third biodegradable polymer. In one embodiment, the first and third biodegradable polymers are poly-ε-caprolactone, and the second biodegradable polymer is a mixture of cellulose acetate phthalate and poloxamer. A method for manufacturing the device is also disclosed.

The reduction in the sol-gel temperature of aqueous poloxamer surfactant compositions by the addition of hydrophobic vicinal diols is provided. Lowering of the sol-gel temperature and the gelling efficiency of water-soluble poloxamer block copolymers of polyethylene oxide-b- polypropylene oxide-b-polyethylene oxide has been markedly improved by the addition of small amounts of at least one hydrophobic vicinal diol, such as monoalkyl glycols, monoalkyl glycerols, or monoacyl glycerols. The decrease in the sol-gel temperature facilitates gel formation, and such gels exhibit greater residence time on a surface, particularly those with biological properties.

The invention relates to the technical field of catalyst materials, in particular to a method for synthesizing a dimethyl carbonate catalyst through a hydrothermal method and application. Comprising the following steps: A, preparing poloxamer into a solution, adding HAc and NaClO4, and uniformly mixing to obtain a mixture; b, (NH4) 2Ce (NO3) 6 and H2BDC are added into the mixture in the step A to be stirred, mixed and reacted, the catalyst is obtained through centrifugal separation, washing, soaking, vacuum drying and calcination, crystal grains of the catalyst are reduced, and the specific surface area, the number of acid-base sites and the oxygen vacancy concentration are all greatly improved.